Please wait a minute...

中国生物工程杂志

China Biotechnology
China Biotechnology  2019, Vol. 39 Issue (9): 19-24    DOI: 10.13523/j.cb.20190903
Orginal Article     
Diagnostic Value of CD11c Antigen in Patients with Chronic Lymphocytic Leukemia
ZHAO Si-shu,LIU Lu,LIU Fang,QIU Hai-rong,FAN Lei,LI Jian-yong,WU Yu-jie()
The First Affiliated Hospital with Nanjing Medical University,Jiangsu Province Hospital,Hematology Department,Nanjing 210029,China
Download: HTML   PDF(831KB) HTML
Export: BibTeX | EndNote (RIS)      

Abstract  

Objective: To explore the expression of CD11c antigen in patients with chronic lymphocytic leukemia(CLL),and its clinical diagnostic value,as well as the correlation of CD11c with genetic abnormalities.Methods: 200 cases of CLL,49 cases of MCL were detected for CD11c expression rate and mean fluorescence intensity(MFI)by Multi parameter flow cytometry (FCM).And the relationship between CD11c expression and prognostic markers (ZAP-70 and CD38) expression in 200 CLL patients were compared.At the same time,the fluorescence in situ hybridization(FISH) was used to detecte P53 deletion, 13q14 deletion, ATM deletion, 6q23 deletion,+12 and IGH rearrangement.Then the genetic abnormalities were compared between CD11c - and CD11c + CLL patients. Results: The CD11c positive rate in CLL patients was 49.5%(99/200),MFI median 2.06(1.00 to7.34).While the CD11c positive rate in MCL patients was 6.12%(3/49).MFI median 2.00(1.97 to 2.54).The positive rate of CD11c expression were significantly higher in CLL patients than in MCL patients(x 2=30.62,P<0.05).The positive rate of ZAP-70 and CD38 were significantly higher in CD11c +CLL patients than CD11c -CLL patients(x 2=15.472,P<0.05;x 2=11.556,P<0.05). The results of P53 deletion, 13q14 deletion,ATM deletion,6q23 deletion,+12 and IGH rearrangement were all not significantly different between CD11c - and CD11c + CLL patients. Conclusion: CD11c has significant value for assistant diagnosis of CLL,especially for the differential diagnosis between CLL and MCL.



Key wordsCD11c      Chronic lymphocytic leukemia      Flow cytometry     
Received: 22 August 2019      Published: 20 September 2019
ZTFLH:  R552  
Corresponding Authors: Yu-jie WU     E-mail: wuyujiel23456@163.com
Cite this article:

ZHAO Si-shu,LIU Lu,LIU Fang,QIU Hai-rong,FAN Lei,LI Jian-yong,WU Yu-jie. Diagnostic Value of CD11c Antigen in Patients with Chronic Lymphocytic Leukemia. China Biotechnology, 2019, 39(9): 19-24.

URL:

https://manu60.magtech.com.cn/biotech/10.13523/j.cb.20190903     OR     https://manu60.magtech.com.cn/biotech/Y2019/V39/I9/19

Fig.1 Immunophenotype of a typical CLL case (a) Lymphocyte (AS) and granulocyte (AT) (b) CD19+ B lymphocyte (AR) (c) CD19+CD5+ lymphocyte (d) CD19+FMC7- lymphocyte (e) CD19+CD23+ lymphocyte (f) CD19+CD22- lymphocyte (g) Kappadimlambda- lymphocyte (h) CD19+CD11c+ lymphocyte
CD11c+ n=99 CD11c- n=101 P x2
ZAP-70+ 43 18 0.000 15.472
ZAP-70- 56 83
CD38+ 56 33 0.01 11.556
CD38- 43 68
Table 1 Comparing the expression of CD11c with the expression of ZAP-70 and CD38 in CLL
P53缺失 13q14缺失 ATM缺失 6q23缺失 +12 IGH重排
阳性 阴性 合计 阳性 阴性 合计 阳性 阴性 合计 阳性 阴性 合计 阳性 阴性 合计 阳性 阴性 合计
CD11C+ 8 62 70 24 31 55 6 49 55 0 52 52 10 42 52 35 34 69
CD11c- 12 63 75 32 20 52 10 45 55 2 50 52 6 46 52 37 32 69
x2 0.636 3.434 1.170 2.039 1.182 0.116
P 0.425 0.064 0.279 0.495 0.277 0.733
Table 2 Comparing the expression of CD11c with molecular genetic in CLL
[1]   Takenaka S , McCormick S, Safroneeva E,et al.Influence of the tissue microenvironment on Toll-like receptor expression by CD11c+ antigen-presenting cells isolated from mucosal tissues. Clin Vaccine Immunol, 2009,16(11):1615-1623.
[2]   Steven H S, Elias C. 《造血与淋巴组织肿瘤WHO分类》.第四版, 北京:诊断病理学杂志社, 2008: 365-492.
[2]   Steven H S, Elias C . WHO classification of tumors of hematopoietic and lymphoid tissue.4 th Edition . Beijing:Chinese Journal of Diagnostic Pathology, 2008: 365-492.
[3]   朱立华 . 高表达CD22/CD11c双阳性细胞群在诊断毛细胞白血病中的应用. 中华检验医学杂, 1997,20(2):106-108.
[3]   Zhu L H . High expression of CD22/CD11c in the diagnosis of hairy cell leukemia. Chinese Journal of Laboratory Medicine, 1997,20(2):106-108.
[4]   Hanson C A, Gribbin T E, Schnitzer B , et al. CD11c (LEU-M5) expression characterizes a B-cell chronic lymphoproliferative disorder with features of both chronic lymphocytic leukemia and hairy cell leukemia. Blood, 1990,76(11):2360-2367.
[5]   Perkovic S, Basic-Kinda S, Aurer I , et al. Multiparameter flow cytometry is necessary for detection,characterization and diagnostics of composite mature B-cell lymphoproliferative neoplasms. Int J Hematol, 2013,98(5):589-596.
doi: 10.1007/s12185-013-1432-7
[6]   Medd P G, Clark N, Leyden K , et al. A novel scoring system combining expression of CD23, CD20, and CD38 with platelet count predicts for the presence of the t(11;14) translocation of mantle cell lymphoma. Cytometry B Clin Cytom, 2011,80(4):230-237.
[7]   Julius M C, Robert E L, Rachel N W , et al. Zap-70 and CD38 as predictors of IgVH mutation in CLL. Experimental and Molecular Pathology, 2007,83(3):459-461.
doi: 10.1016/j.yexmp.2007.08.009
[8]   徐卫, 李建勇, 潘金兰 , 等. 双色荧光原位杂交技术检测慢性淋巴细胞白血病IGH基因易位. 中华检验医学杂, 2006,29(8):711-713.
[8]   Xu W, Li J Y, Pan J L , et al. Detection of IgH gene translocation in chronic lymphocytic leukemia by dual-color fluorescence in situ hybridization. Chinese Journal of Laboratory Medicine, 2006,29(8):711-713.
[9]   Daniela L ,Martin J S D, Jose M G,et al. p53 abnormalities in CLL are associated with excess of prolymphocytes and poor prognosis. British Journal of Haematology, 1997,99(4):848-857.
[10]   Michele D B ,Rossi F M,Rossi D, et al. 13q14 deletion size and number of deleted cells both influence prognosis in chronic lymphocyticleukemia, 2011,50(8):633-643.
[1] HE Ling-ling,LUO Ting-ting,CHANG Yan,WANG Ya-zhe,YUAN Xiao-ying,SHI Wei-hua,LAI Yue-yun,SHI Hong-xia,QIN Ya-zhen,HUANG Xiao-jun,LIU Yan-rong. Analysis on the Laboratory Examination Characteristics in 28 Patients with Acute Megakaryoblastic Leukemia[J]. China Biotechnology, 2019, 39(9): 2-10.
[2] YUAN Xiao-ying,WANG Ya-zhe,SHI Wei-hua,CHANG Yan,HAO Le,HE Ling-ling,SHI Hong-xia,HUANG Xiao-jun,LIU Yan-rong. Methodological Study on Flow Detection of PNH Clone and Its Clinical Screening Significance[J]. China Biotechnology, 2019, 39(9): 33-40.
[3] HUI Yi-hua,WANG Hai-na,QI Yu-feng,CAO Xue-ling,GUAN Xue-mei,DUAN Jing-jing,DUAN Yi- jun,WANG Yan- feng,SU Wen. Normal Reference Range of Lymphocyte Subsets in Healthy Adults in Shanxi Province[J]. China Biotechnology, 2019, 39(9): 41-49.
[4] Hang Hai-ying,Liu Chun-chun,Ren Dan-dan. Development, Application and Prospection of Flow Cytometry[J]. China Biotechnology, 2019, 39(9): 68-83.
[5] PENG Xian-gui,YANG Wu-chen,LI Jia,GOU Yang,WANG Ping,LIU Si-heng,ZHANG Yun,LI Yi,ZHANG Xi. The Application of Related Cytomorphological Technology in Hematological Neoplasms Research Progress[J]. China Biotechnology, 2019, 39(9): 84-90.
[6] WEI Jin-mei, FAN Xiao-qin, XIONG Hai-ting, GAO Xue-juan, LIU Xiao-hui, LIU Lang-xia. hnRNPK Interacts with Nef and Facilitates the Cell Surface Expression of CD4[J]. China Biotechnology, 2015, 35(4): 17-22.
[7] . Effects of Serum Deprivation,Confluence and Cycloheximide[J]. China Biotechnology, 2008, 28(12): 57-61.
[8] . Effect of flow cytometrically-sorted sperm on chromosomes of bovine blastocysts produced in vitro[J]. China Biotechnology, 2007, 27(1): 98-101.
[9] . The investigation of the effect on human Hepatoma Cell apoptosis induced by Resibufogenin[J]. China Biotechnology, 2006, 26(06): 36-39.